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a b s t r a c t
Despite aggressive peri-operative antibiotic treatments, up to 10% of patients undergoing instrumented
spinal surgery develop an infection. Like most implant-associated infections, spinal infections persist
through colonization and biofilm formation on spinal instrumentation, which can include metal screws
and rods for fixation and an intervertebral cage commonly comprised of polyether ether ketone
(PEEK). We have designed a PEEK antibiotic reservoir that would clip to the metal fixation rod and that
would achieve slow antibiotic release over several days, followed by a bolus release of antibiotics trig-
gered by ultrasound (US) rupture of a reservoir membrane. We have found using human physiological
fluid (synovial fluid), that higher levels (100–500 lg) of vancomycin are required to achieve a marked
reduction in adherent bacteria vs. that seen in the common bacterial medium, trypticase soy broth. To
achieve these levels of release, we applied a polylactic acid coating to a porous PEEK puck, which exhib-
ited both slow and US-triggered release. This design was further refined to a one-hole or two-hole cylin-
drical PEEK reservoir that can clip onto a spinal rod for clinical use. Short-term release of high levels of
antibiotic (340 ± 168 lg), followed by US-triggered release was measured (7420 ± 2992 lg at 48 h).
These levels are sufficient to prevent adhesion of Staphylococcus aureus to implant materials. This study
demonstrates the feasibility of an US-mediated antibiotic delivery device, which could be a potent
weapon against spinal surgical site infection.
Statement of Significance
Spinal surgical sites are prone to bacterial colonization, due to presence of instrumentation, long surgical
times, and the surgical creation of a dead space (5 cm3) that is filled with wound exudate. Accordingly,
it is critical that new approaches are developed to prevent bacterial colonization of spinal implants, espe-
cially as neither bulk release systems nor controlled release systems are available for the spine. This new
device uses non-invasive ultrasound (US) to trigger bulk release of supra-therapeutic doses of antibiotics
from materials commonly used in existing surgical implants. Thus, our new delivery system satisfies this
critical need to eradicate surviving bacteria, prevent resistance, and markedly lower spinal infection rates.
 2019 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Placement of implants, instrumentation, and/or bone supple-
mentation are critical to orthopaedics with implant-associated
infection an infrequent, but devastating complication. The inci-
dence of post-surgical infections depends on the site, and ranges
from <1 to 2% for joint replacements [1] and up to 10% for spinal
https://doi.org/10.1016/j.actbio.2019.02.041
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surgeries [2]. Unfortunately, infection rates also depend on the
health of the patient and are expected to increase among the aging,
diabetic, obese, and those with metabolic syndrome and other dis-
eases/treatments that affect immune status [3].
Instrument-associated infections which exhibit attenuated
immune surveillance arise from bacterial biofilms. These biofilms
exhibit reduced responses to antibiotics due to bacterial sequestra-
tion, changes in gene expression, and ultimately biofilm formation
[4]. Thus, we and others have sought to eradicate bacteria early to
prevent biofilm formation and the subsequent seeding of new
infections. Current antibacterial systems encompass release of sil-
ver nanoparticles [5,6], bioactive antibacterial surfaces including
those with long-term, permanent antimicrobial activity [7–9],
and controlled antibiotic release systems [10–12]. In the spine,
prophylaxis is achieved by inclusion of 1–2 g of vancomycin
(VAN) powder during closure [13] to sterilize the site post-
surgically. The outcome of this procedure is mixed since VAN
reduces the number of infections associated with Gram-positive
bacteria (such as the Staphylococci), but the number of infections
attributed to Gram-negative bacteria may increase [14].
Like other implant-associated infections [15], it is likely that
spinal instrumentation (e.g., metal screws, rods, and cages, usually
made of porous metal or of polyether ether ketone(PEEK) [16])-
associated infections persist through bacterial colonization and
biofilm formation. Interestingly, unlike the joint, spinal infections
are more often successfully treated by aggressive antibiotic treat-
ments [17]. However, failure to effectively treat an infection can
be life threatening, as spinal instrumentation may be required for
spinal stability precluding removal.
In the spine, the metal instrumentation exists at the interface of
muscle and bone, and at least initially is bathed in post-operative
wound fluid. This wound fluid may influence bacterial properties
as we and others have shown that methicillin-sensitive Staphylo-
coccus aureus (MSSA), methicillin-resistant Staphylococcus aureus
(MRSA), and Staphylococcus epidermidis form >100 mm proteina-
ceous aggregates and biofilms in blood and synovial fluid (SynF)
[18–20]. Aggregation appears to be dependent on the presence of
extracellular matrix proteins, including fibrin [19]. Interestingly,
fibrous aggregates in blood, as well as surface-bound biofilms,
can be permeabilized through application of ultrasound (US),
enhancing drug access and efficacy [21–23]. Specifically, US
enhances tissue penetration and this penetration can be further
enhanced by mechanical disruption of drug-containing nano- and
micro-particles, and micelles [24–27]. US-triggered cavitation
and rupture of these microbubbles and micelles is well-
characterized [28–35], with recent applications for targeted drug
delivery [36–39]. These drug-containing bubbles include thin-
shelled polymer [40] and polylactic acid (PLA) [41,42] microbub-
bles, which are tunable for response to focused US in a drug deliv-
ery setting and we will use this property in our design.
Thus, we hypothesized that application of US would mechani-
cally rupture a PLA membrane coating a clip with a reservoir. We
then suggested that this insonation would cause streaming of
drugs out of the reservoir, to result in a non-invasive release of
supratherapeutic levels of VAN (Fig. 1). We chose to characterize
VAN in this setting as it is already used prophylactically in spinal
surgery [13,14,43]. To evaluate these hypotheses, we followed an
iterative design process in order to arrive at a clinically-relevant
prototype device. We first determined the free VAN concentration
that would be required to maintain sterility of the PEEK device in
the face of an MSSA challenge as a function of ideal media or phys-
iological fluid. We next examined if milligram amounts of VAN
could be sealed into and released from a model porous PEEK puck
(First Generation). It was important in this early stage to determine
the overall feasibility of the US-triggered release response from a
PEEK device. We then built upon our findings with these first gen-
eration devices to design more clinically-relevant bulk antibiotic
reservoirs in C-shaped clips (Second Generation), and evaluated
release characteristics from these refined devices both in vitro
and in an ex vivo animal model.
2. Materials and methods
2.1. Fabrication Conditions
PEEK discs were additively manufactured using a PEEKMed fil-
ament (Apium Additive Technologies, Karlsruhe, Germany) using
an Indmatec HPP 155/Gen 2 3D printer (Apium Additive Technolo-
gies). The discs were printed with a 0.4 mm nozzle at a speed of
1500 mm/min and a layer thickness of 0.1 mm. The filament extru-
der temperature was 405 C and print bed temperature 100 C. The
printing process of the disc produced two different surface finishes
of the disc faces: one smooth (the face in contact with the glass
print bed) and one with a rougher surface finish. For the strain
growth and biofilm formation experiments, we used the smooth
face of the discs. Tissue culture polystyrene (PS, Corning Costar,
Fisher Scientific, Hampton, NH) was used as a control. All surfaces
were sterilized by incubation in 70% ethanol in water and 15 min
exposure to UV light.
2.2. Strain growth and biofilm formation
Two strains of methicillin-sensitive Staphylococcus aureus
(MSSA) were used. ATCC25923TM was used for all in vitro experi-
ments whereas, to allow easy strain identification, the superfolder
GFP-containing strain AH1710 [44] was used for experiments in
rabbit cadavers. Overnight MSSA cultures were subcultured, 2 hr
and diluted in trypticase soy broth (TSB) or human synovial fluid
(SynF, ‘‘discarded” from joint aspirations (approved by TJU IRB))
to 105 colony forming units (CFU)/ml using a 0.5 McFarland stan-
dard (turbidity standard where A600 of 0.10 yields 1  108 CFU/
ml). Inoculated surfaces were incubated under static conditions
to facilitate biofilm formation. Upon harvesting, surfaces were
gently washed 3X with PBS to remove nonadherent bacteria and
either (i) fixed and visualized with scanning electron microscopy
(SEM) or (ii) adherent bacteria suspended by 15 min sonication
in 0.3% Tween 20 in PBS, followed by serial dilution, plating on
3 MTM PetriFilmsTM (3 M Corp, St. Paul, MN), and digital recording.
Dilutions with 20–500 CFU/film were counted and numbers
expressed as CFU/ml.
2.3. Microscopy and contact angle measurements
80  80 mm areas of PEEK and PS discs were probed for surface
roughness using an Asylum MFP-3D atomic force microscope
(AFM, Asylum Research, Oxford Instruments) operated in tapping
mode in air. Root mean square (RMS) roughness was calculated
from topographic images after plane subtraction and drift correc-
tion. Four samples of each surface type were assessed. For visual-
ization with scanning electron microscopy (SEM), surfaces with
biofilms were fixed with 4% paraformaldehyde, 1 h; dehydrated
with an ethanol series, air-dried overnight, sputter-coated with
gold, and visualized using a Hitachi TM-1000 SEM (Hitachi High-
Technologies). For each condition, at least 3 independent surfaces
were assessed.
Rough contact angles were measured on dry surfaces or after
pre-incubation in SynF, or TSB for 1 hr at room temperature. Per-
pendicular views of droplets formed with 10 mL of distilled water
were recorded digitally and angles measured using two methods
– (1) direct measurement of the angle of the intersection with
the surface of (2) measurement of the heights and the radii of
the drops, followed by calculation of the angles from their ratios.
2 L.J. Delaney et al. / Acta Biomaterialia xxx (xxxx) xxx
Please cite this article as: L. J. Delaney, D. MacDonald, J. Leung et al., Ultrasound-triggered antibiotic release from PEEK clips to prevent spinal fusion infec-
tion: Initial evaluations, Acta Biomaterialia, https://doi.org/10.1016/j.actbio.2019.02.041
2.4. First generation porous PEEK pucks
Additively manufactured (using the printing parameters men-
tioned above), porous PEEK pucks (1 cm diameter  0.5 cm height)
were loaded with 0.5 ml of a 100 mg/ml solution of VAN (50 mg;
pharmaceutical grade, Athenex, Buffalo, NY) in water and frozen
overnight,20 C, to create a solid surface for PLA coating. A subset
of loaded pucks were coated with a PLA membrane by dipping the
frozen puck in a solution of 1 g PLA (75–120 kDa, Resomer Select
100 DL 7E PLA, Evonik Industries, Essen, Germany) in 30 ml chloro-
form (CHCl3, Fisher Scientific), followed by overnight air-drying at
room temperature.
Coated, antibiotic-loaded pucks were submerged in 5 ml TSB
containing 105 CFU/ml ATCC25923TM. Individual pucks were inso-
nated by US for 10 min with a SonoScape S9 with an L742 probe
(SonoScape, Shenzhen, China) in power Doppler mode at a fre-
quency of 7.2 MHz, pulse repetition frequency of 8 kHz, and 100%
acoustic output power. One and 24 hr after insonation, antibiotic
release was determined by sampling 50 lL from each well, fol-
lowed by spotting and drying onto a BD BBLTM blank Sensi-DiskTM
(Becton Dickinson, Franklin Lakes, NJ). The disc was then placed
onto a TSB agar plate containing a lawn of ATCC25923TM, and, after
overnight incubation, 37 C, the zone of inhibition due to VAN dif-
fusion measured [45]. VAN amounts were estimated by compar-
ison to a standard curve of VAN concentrations as well as to a
commercial 30 mg VAN standard disc [9,46]. In parallel, planktonic
bacterial survival was measured by plating aliquot dilutions onto
3 MTM PetriFilmsTM. Finally, puck-adherent ATCC25923TM bacteria
were measured at 24 hr (see 2.1). Controls included (1) coated,
loaded pucks, not insonated, (2) loaded, uncoated pucks ± insona-
tion, and (3) bacteria only ± insonation. Results were collected in
triplicate and experiments repeated at least three times.
2.5. Second generation PEEK clips
Building upon our findings with the first generation PEEK pucks,
we refined the design to a more clinically-relevant geometry, and
continued to characterize the devices. C-shaped clips were drafted
with an inner drug reservoir and designed to clip onto a standard
5.5 mm lumbar spinal fusion rod (Fig. 1), using Solidworks 2016
(Dassault Systemes, Vélizy-Villacoublay, France), and exported as
a stereolithography (STL) file. These STL files were sliced and trans-
lated to G-Code, a numerical control programming language used
by 3D printers for coordinates, using commercially available slicing
software (Simplify3D, Cincinnati, OH). Briefly, a 0.785 cm3 reser-
voir was printed into a PEEK clip using a PEEKMed filament on
an Indmatec HPP 155/Gen 2 3D printer (Apium) [47]. These
semi-circular clips contained either one 4 mm diameter opening
(1-hole), or two 2 mm openings (2-hole). The two device designs
were evaluated to compare membrane stability, as well as VAN
elution time. Printed clips were evaluated for height, width, diam-
eter, wall thickness, horizontal channel, vertical channel, and
porosity using computer tomography (Scanco lCT 80, Scanco Med-
ical, Brüttisellen, Switzerland) at 0.01 mm voxel resolution and
compared to design dimensions.
To evaluate membrane stability, methylene blue (MeB), an
intense dye which is widely used to visualize drug release [48–
51], was used to visualize structural integrity of the membrane
before and after insonation. Both the 1-hole and 2-hole clips were
loaded with 120 mg of powdered MeB, or with 125 mg using a
200 mg/ml solution of MeB that was frozen to create a solid surface
for coating. Loaded clips (4/group) were coated by submersion and
withdrawal in a solution of (1) 50 mg/ml PLA/CHCl3 for 5 times (5–
50 group), (2) 50 mg/ml PLA/CHCl3 for 10 times (10–50 group), or
(3) 250 mg/ml PLA/CHCl3 5 times (5–250 group); all clips were
dried under continuous air-flow at room temperature for 24 hr.
PLA deposition was determined by weight difference before and
after coating. One clip from each group was sputter coated with
platinum-palladium and surface morphology determined by
acquisition of 3 random images using SEM (Philips FEI XL 30 Envi-
ronmental SEM (Philips, Hillsboro, OR)).
To test for release and stability, these PLA coated, MeB-loaded
clips were submerged in 200 ml PBS at 37 C with moderate shak-
ing (90 rpm) and release was evaluated spectrophotometrically
Fig. 1. Representation of loaded, sealed spinal clip (A) and porous PEEK puck (B) (elements not shown to scale). The clip (A) is shown with one-hole where the C-shaped area
is for attachment to the spinal rod. The puck (B) has an array of pores. The coating on top of the reservoirs is insonated by US, causing rupture of the PLA coating to release the
vancomycin (VAN).
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(k = 600 nm; Tecan Infinite M1000, Männedorf, Switzerland) over a
period of 7 days, where 1 ml was collected from the bulk liquid
every 24 hr. After 7 days of incubation, clips were insonated using
a SonixRP scanner equipped with an L4-9 probe (Analogic Ultra-
sound, Richmond, British Columbia, Canada) at a frequency of
5 MHz with a 3 MPa peak-to-peak acoustic output pressure. MeB
release from the reservoir was determined as above. Results were
collected in triplicate.
Burst release from uncoated MeB-loaded PEEK clips (both 1-
hole and 2-hole designs) was determined while submerged in
200 ml PBS at 37 C and shaken at 90 rpm to simulate biological
fluid flow. Media was sampled and refreshed every 30 min for 10
hr and release was measured spectrophotometrically (as above).
Release data was fit by linear regression to determine the diffusion
coefficient, Do, for comparison with published values. Release from
the PEEK clip was modeled using the principle of Noyes-Whitney
dissolution and diffusion [52–57]. Under biological conditions
where constant immersion is assumed, solid drug will constantly
dissolve and diffuse out of the porous PEEK clip to reach a steady
state. Our model considers two routes of drug release: linear
release from the drug delivery channel (NC) and radial release from
the porous cylindrical walls of the clip device (NW). Total drug
release from the clip is described by the release rate (QT), as shown
in Eq. (1) (variables defined in Table 1).
dQT
dt
¼ DO ACHANMo
ðCs  CoÞ
x
þ Doe
Ro  s Mo
CS  ACYL
ln Ri=Roð Þ ð1Þ
VAN release from these second generation clips was evaluated
in vitro in the same way the first generation clips were tested. Both
the 1-hole and 2-hole PEEK clips were loaded with 150 mL of a
400 mg/ml solution of VAN (60 mg total) in water and frozen over-
night, 20 C, to create a solid surface for PLA coating. A subset of
loaded clips were coated with a PLA membrane by dipping the fro-
zen clip in a solution of 1 g PLA in 30 ml chloroform, followed by
overnight air-drying at room temperature, as detailed for previous
methods. Prepared clips were submerged in 5 ml TSB and inso-
nated for 10 min with the same settings described previously.
One and 24 hr after insonation, antibiotic release was determined
by sampling 50 lL from each well, followed by spotting and drying
onto a BD BBLTM disc, which was then placed onto a TSB agar plate
containing a lawn of ATCC25923TM, and, after overnight incuba-
tion, 37 C, the zone of inhibition due to VAN diffusion measured.
VAN amounts were estimated by comparison to a standard curve
of VAN concentrations as well as to a commercial 30 mg VAN stan-
dard disc.
2.6. Ex vivo evaluation of antibiotic release
US-triggered release of VAN from 1- and 2-hole PEEK clips was
evaluated in a cadaveric rabbit model. Devices were loaded until
filled with a slurry of 400 mg/ml VAN in water (125 mL slurry/-
clip = 50 mg VAN), frozen to create a solid surface for PLA coating,
coated using the 5–50 protocol, and dried at room temperature for
24 hr. VAN-loaded, coated devices were sterilized by incubation in
70% ethanol (30 min) and implanted into cadaveric, mature
(6 months, 3 kg), female White New Zealand rabbits (n = 4, Cov-
ance, Princeton, NJ) under an IACUC-approved protocol. Specifi-
cally, 4 incisions were made medial to the midline of the spine;
loaded, coated devices were placed in all 4 sites, and 104 CFU S.
aureus AH1710 were added to 2 of the sites (Table 2). Wounds
were closed with Proline 2.0 suture (Ethicon, Somerville, NJ), fol-
lowed by insonation of 2 of the 4 sites for 20 min with a Logiq
E9 clinical US scanner (GE Healthcare, Milwaukee, WI) equipped
with a C1-6 curvilinear probe, using power Doppler imaging
(1.7 MHz frequency, 6.4 kHz PRF, 100% acoustic output power) to
induce cavitation and rupture of the PLA coating for VAN release
(Table 2). In parallel, positive and negative bacterial controls were
evaluated, where the surgical procedure was performed without
PEEK devices or insonation, and S. aureus AH1710 added to 2 of
the 4 surgical sites. All sites were incubated for 2 h, then retrieved
for analysis. To confirm retrieval of GFP-labeled bacteria, sites were
swabbed and the PBS-soaked swab spread onto a TSB agar plate.
VAN release from the devices was quantified by zones of inhibition
(see 2.3). Results were collected in duplicate for each evaluated
device and condition.
2.7. Statistical analysis
All statistical testing was done using Prism 7 (GraphPad, San
Diego, CA) using a = 0.05 significance level. Error bars are dis-
played as standard deviation (SD). Comparison between clip design
dimensions and actual device dimensions was performed using a
two-tailed t-test. Statistically significant differences for multiple
groups were determined using a one-way ANOVA with Bonferroni
correction for multiple comparisons and Tukey’s multiple compar-
ison post-test when appropriate. Differences were evaluated across
all groups, and also within each group for more robust analysis.
3. Results
3.1. Strain growth and biofilm formation
We first evaluated S. aureus ATCC25923TM adhesion on PEEK
and PS (control) surfaces to determine biofilmmorphology and col-
onization as a function of media. On the PEEK surface at 24 hr,
ATCC25923TM appeared to be already encased in a biofilm in both
Table 1
Parameters used in the model and their corresponding values.
Parameter Description Value
Experimental dQT/dt
Do
Release Rate
Diffusion Coefficient
3.27%/h
7.16  108 m2/s
Solidworks ACHAN Cross-Sectional Area of
Channel
7 mm2
ACYL Cylindrical Surface Area of
Clip
339 mm2
x Wall Thickness 1.5 mm
Ro Outer Radius of Clip 6 mm
Ri Inner Radius of Clip 4.5 mm
Mo Initial Mass of Loaded Drug 120 mg
lCT e Porosity 0.38
Literature CS Solubility of MeB in Water 4.36  107 mg/
m3
s Tortuosity Factor 3
CO Concentration of MeB in
Water
0
Experimental parameters were determined through the burst release experiment,
designed parameters are controlled through the design of the clip, porosity was
evaluated via lCT, and literature values were found in scientific publications.
[55,80]. Concentration of MeB in water is considered as zero, since the media
surrounding the clip is considered an infinite sink.
Table 2
Experimental conditions for ex vivo device evaluation.
Head
Site 1 (+MSSA AH1710, US) Site 4 (MSSA, US)
Site 2 (+MSSA AH1710, +US) Site 3 (MSSA, +US)
Tail
Table is arranged to depict actual device placement during experiment: middle line
represents the midline/spine, MSSA (AH1710)-positive conditions were kept on the
left to prevent cross contamination of surgical sites, while US-positive conditions
were kept on the bottom to prevent accidental insonation of other sites.
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the ideal medium TSB (Fig. 2Aa), and after incubation in SynF
(Fig. 2Ac). ATCC25923TM colonization of PS surfaces appeared
abundant in TSB (Fig. 2Ab); in SynF, the bacteria organized into
three-dimensional, fibrous aggregates (Fig. 2Ad). When bacterial
colonies were retrieved from the surfaces, PEEK was more abun-
dantly colonized than PS in TSB and in SynF (p < 0.0001, Fig. 2B).
Of interest, colonization of both PEEK and PS appeared 4-fold
lower in SynF than in TSB. Thus, while both surfaces are abun-
dantly colonized, fibrous aggregates may influence apparent bacte-
rial counts.
We next tested whether bacteria were able to colonize the sur-
face in the presence of VAN. At all times and on both PS and PEEK,
10 mg/ml VAN effectively lowered numbers of adherent bacteria by
2.5–4 logs (102.5–104 decrease) when cultured in TSB (Fig. 3A and
B; p < 0.0001 for all times when comparing 10 mg/ml VAN to 0 mg/
ml VAN). VAN was less effective in SynF, achieving limited long-
term reduction in CFU (Fig. 3C and D; p < 0.0001 for all 0 vs.
10 mg/ml VAN) except at 48 h on PS (p = 0.0011) and 18 and 24 h
on PEEK (p = 0.0003 and 0.3, respectively).
We next tested how much VAN would be required to minimize
ATCC25923TM colonization of the surfaces. A dose of 100 mg/ml is
the minimum dose for eradication of bacteria from PEEK or PS in
TSB (p < 0.008). Large variance in bacterial counts is present at
the 10 mg/ml dose in PEEK/TSB, representing inconsistent bacterial
response to VAN. (Fig. 4A). A dose of 500 mg/ml is the minimum
dose for eradication of bacteria from PEEK or PS in SynF
(p < 0.0001). Significant reduction in bacterial adhesion is observed
at 10 mg/ml (p < 0.0001, compared to 0 mg/ml) and again at 100 mg/
ml (p < 0.0001, compared to both 0 mg/ml and 10 mg/ml) but adher-
ent bacteria are not fully eradicated at either dose (Fig. 4B). This
difference is potentially due to the aggregation and antibiotic
recalcitrance previously reported [19,20].
3.2. Microscopy and contact angle measurements
As bacterial adherence is affected by surfaces properties, we
characterized roughness and wettability for PEEK and PS. By
SEM, 3D-printed PEEK surfaces (Fig. 5Aa) appeared rougher than
PS (Fig. 5Ab), and it appeared that the PEEK surfaces had small
amounts of fabrication debris. AFM analysis showed regular deep
pits and topographic highs in the PEEK sample (Fig. 5Ba), whereas
the PS sample showed only small variations (Fig. 5Bb). These topo-
graphic differences were more apparent in 3D views where the
additive-manufactured PEEK sample (Fig. 5Ca) showed 10X
greater RMS roughness than the PS sample (Fig. 5Cb). Contact angle
measurements (Table 3) indicated that the dry surfaces were less
hydrophilic than those that had been pre-conditioned with TSB
or SynF. However, TSB markedly changed wettability of PEEK
(54 vs. 28) but less so for PS (69 vs. 64). Pre-coating with SynF
caused both the PEEK and PS samples (contact angles 20 and 0,
respectively) to become hydrophilic.
3.3. First generation porous PEEK pucks
Having defined efficacious antibiotic amounts, we set out to
develop a PLA coating that could be ruptured with US. The VAN-
loaded and PLA-coated PEEK pucks were insonated with US in
the presence of bathing MSSA. VAN was released due to rupture
of the coating (Fig. 6) and, after 24 hr, particulates that are most
likely VAN, could be visualized in the bottom of all wells holding
VAN-loaded pucks, i.e., insonated coated, insonated uncoated or
non-insonated uncoated. All VAN-loaded pucks, regardless of coat-
ing or insonation, caused eradication of the bathing planktonic
MSSA ATCC25923TM (data not shown). At all time points, samples
taken from unloaded, uncoated, and non-insonated PEEK pucks
showed no inherent antimicrobial activity compared to free
growth controls (p > 0.99). It is worth noting that control experi-
ments determined that insonation with US had no effect on bacte-
rial survival (p > 0.99). When the pucks were examined for VAN
release (Fig. 6C), a background release of VAN averaging
340 ± 168 lg was measured prior to insonation. Upon insonation
(t = 0), an average of 760 ± 159 lg was measured; this release
was significantly greater than the background release (p = 0.005).
Release at 1 h (1000 ± 192 lg) was not significant compared to
t = 0 (p = 0.4); nor was release at 24 h (2140 ± 952 lg) compared
to t = 0 (p = 0.08) or t = 1 h (p = 0.2). Using average cumulative
release, VAN release increased markedly with time (p = 0.0002).
Immediately following insonation, an average cumulative release
of 1.1 ± 0.3 mg was measured (p = 0.0004 compared to before
US); at 1 hr, average cumulative release was 2.1 ± 0.3 mg
(p = 0.0003 compared to t = 0), and at 24 h, total release was
4 ± 1 mg out of a total of 50 mg loaded into each puck
(p = 0.001 compared to before US, p = 0.003 compared to t = 0,
and p = 0.01 compared to t = 1).
Fig. 2. Colonization of PEEK or PS in indicated media. (A) MSSA colonization of PEEK
(a,c) and PS (b,d) in TSB (a,b) or SynF (c,d) is shown by SEM. Magnification:
bar = 15 lm. (B) Numbers of adherent bacteria on PEEK or PS in TSB (left) or SynF
(right) expressed as colony forming units (CFU)/ml. Results are average ± SD, where
n = 6 in at least 3 similar, independent experiments. All values are significantly
different (p < 0.0001).
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3.4. Second generation PEEK clips
After successfully releasing sufficient quantities of VAN to erad-
icate all bacteria, and confirming the feasibility of the US-triggered
release in a basic puck design, we investigated whether we could
translate this US-mediated release using a reservoir that would
fit onto spinal rods. Two C-shaped PEEK clip designs, a 1-hole clip
and a 2-hole clip, were manufactured and characterized. Dimen-
sional accuracy of the PEEK clip prototypes was verified with lCT
measurements, with no significant difference found between
designed and measured dimensions (p > 0.9, data not shown).
Evaluating the coating process for both the 1-hole and 2- hole
clip designs, PLA deposition on the clips appeared successful, but
was variable for both the 5–50 and the 10–50 techniques (on aver-
age 47 ± 56 mg of PLA for the 5–50 technique vs. 87 ± 105 mg for
the 10–50 technique; p = 0.005). The 5–250 coatings were more
consistent (average PLA deposit = 214 ± 57 mg) and deposited sig-
nificantly greater amounts of PLA than the other techniques
(p < 0.0001). These findings are consistent with the coating mor-
phology observed via SEM imaging (Fig. 7A). The coatings observed
with the 5–50 (Fig. 7Ab) and 10–50 (Fig. 7Ac) techniques were
heterogeneous, with porosity still apparent; the 5–250 technique
(Fig. 7Ad) completely covered the PEEK surface and its pores.
Quantitatively for both the 1-hole and 2-hole clip designs, the 5–
50 coating showed the greatest innate release over time
(24 ± 3%), followed by the 10–50 coating (17 ± 7%), as shown in
Fig. 7B. The 5–250 coating retained the MeB for the 7 days of the
trial (0.6 ± 0.6%, p < 0.01).
When the clip membranes were ruptured by US insonation,
small gas bubbles were seen escaping from the reservoir inside
the PEEK clips and MeB was observed streaming from the reservoir
into the surrounding PBS (Fig. 7C, with the 1-hole clip design as a
visual example); however, concentrations were not measured
post-insonation, due to loss of fluid. While the 5–250 coating
allowed more stable retention of material, the 5–50 coating
showed more reproducible rupture in both the one-hole and
two-hole designs and was used in the in vitro and ex vivo VAN
release experiments.
Evaluation of burst release from the one-hole PEEK clips
revealed that release was linear, and aligned with the model (cf.,
Eq. (1)), with a rate of 3.3% per hour over the first three hours of
submersion (r2 > 0.99, data not shown); similar rates were
observed for the two-hole PEEK clips. Using published values for
spherical pore tortuosity factor and MeB solubility, the diffusion
coefficient of MeB was calculated as 7.2  108 m2/s [55,57–59].
Beyond 8 hr, the cumulative release of MeB asymptotically reached
98%, signifying the complete emptying of the reservoir contents
into the submersion medium. We also evaluated both the one-
hole and two-hole clip designs for VAN release from the uncoated
clips under static conditions. There was significantly greater total
VAN release from the one-hole design (772 ± 66 mg) than from
the two-hole clip (512 ± 115 mg, p = 0.01).
When the clips were examined for US-triggered VAN release
(Fig. 8), the PLA membrane on the one-hole design appeared to
be more stable and responsive to insonation than with the two-
hole design. Background release for the coated, uninsonated one-
hole clip was 5 ± 6 mg after submersion for 1 h, while the two-
hole clip released 20 ± 5 mg over the same time (p = 0.01). This
was also the case at 24 h, where the two-hole clips released
453 ± 3 mg VAN, while the one-hole design released significantly
less VAN (169 ± 3 mg, p < 0.0001). Additionally, the two-hole clip
showed no significant difference between the insonated and unin-
sonated samples (Fig. 8B) at any of the time points (p > 0.8). Con-
versely, the one-hole clip design showed that VAN release
increased markedly with time (p < 0.0001, Fig. 8A). One hour fol-
lowing insonation, an average release of 74.7 ± 0.6 mg was mea-
sured (p = 0.0002 compared to uninsonated). After 24 h, the total
cumulative release from the insonated one-hole clips was
527 ± 32 mg (p = 0.0002 compared to uninsonated). Comparatively,
there was no significant difference in total US-triggered VAN
release between the one-hole design and the two-hole design
(486 ± 107 mg, p = 0.3). Therefore, we continued to evaluate
Fig. 3. MSSA colonization of PEEK or PS in TSB or SynF over time. Graphs are MSSA incubated in TSB (A and B) or SynF (C and D) on PEEK (A and C) or PS (B and D). Each graph
shows colonization on control compared to that in the presence of 10 mg/ml VAN. Note that CFU/ml are plotted on a log scale. Numbers of bacteria are represented as CFU/ml
and represent average ± SD (n > 6, with at least 3 similar, independent repeats). For SynF on PS at 18 and 24 h, p values for 0 vs. 10 mg/ml VAN were p = 0.0003 and 0.3,
respectively. For SynF on PEEK, 0 vs. 10 mg/ml VAN at 48 hr achieved a significance of p = 0.001. All other comparisons were significantly different at p < 0.0001.
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both the one-hole and two-hole clip designs in the ex vivo
experiments.
3.5. Ex vivo evaluation of antibiotic release
Based on our successful in vitro evaluation of these clinically-
relevant prophylactic PEEK clips, we studied the characteristics of
US-mediated VAN release and elution in an ex vivo spine model.
Representative images of device implantation and insonation in a
cadaveric, female, New Zealand white rabbit are shown in Fig. 9.
Negative controls indicated no surgical site contamination, and
positive controls confirmed that the GFP-expressing MSSA
AH1710 grew in the wound environment.
In terms of bacterial recovery (data not shown), retrieved bacte-
ria expressed GFP, consistent with recovery of S. aureus AH1710.
Because swabbing is not quantitative, antimicrobial efficacy could
not be enumerated, but numbers of bacteria in sites that had had
VAN release by US appeared less abundant than those with no
facilitated release. VAN release was dependent on the design.
Specifically, using the porous puck, roughly 50% (by weight) of
the encapsulated VAN was released by insonation in vitro, com-
pared with no VAN release from the non-insonated pucks. When
we moved to ex vivo conditions, both the 1-hole and 2-hole clips,
showed time-dependent VAN release. At 48 hr, there was signifi-
cantly greater VAN release from the insonated clips compared to
the uninsonated clips for both designs (p < 0.04; Fig. 9D and E).
There was significantly greater US-triggered total VAN release from
the 1-hole clip design (7420 ± 2992 lg) than from the 2-hole
design (3500 ± 954 lg, p < 0.0001). Thus, the 1-hole clip design
showed a greater release than the 2-hole design, suggesting that
the larger hole may allow the greatest drug release.
4. Discussion
Despite the placement of up to 2 g of VAN during spinal fusion
surgeries, bacteria remain, propagate, and establish an infection in
up to 5.2% of cases [13,14]. These antibiotics are thought to be
depleted by the presence of aseptic drains, commonly removed
at 2 or 3 days. We reasoned that release of a second prophylactic
dose of antibiotics in the post-surgical period (2–7 days) could
eradicate bacteria that escaped the initial prophylaxis. With that
in mind, we designed a system for antibiotic release within the
spine that would achieve a slow release over several days, followed
Fig. 4. Effects of different doses of VAN on MSSA colonization. Adherent MSSA were counted after incubation in the indicated amounts of VAN and expressed as CFU/ml. Note
log scale. Values shown are average ± SD (n = 6, with at least 3 independent repeats). For TSB on PEEK, 0 vs. 10 mg/ml VAN was p = 0.02, 0 vs. 100 mg/ml VAN and 0 vs. 500 mg/
ml VAN were both p = 0.008. For TSB on PS, all comparisons except 100 vs. 500 mg/ml VAN were p < 0.0001. For TSB on PEEK and PS, 100 vs. 500 mg/ml VAN was p > 0.99. For
SynF on PEEK and PS, all comparisons were p < 0.0001.
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by a bolus release of antibiotics triggered by US-induced rupture of
the PLA membrane. VAN release was visibly achieved from all
three device designs. We found that PLA coating of the PEEK
devices is susceptible to US disruption both in vitro and within tis-
sue ex vivo, with up to 7.4 mg of VAN delivered within 48 hr. Our
result was a viable prototype (i.e., the 1-hole clip) for US-
mediated localized prophylactic delivery to the spinal surgical site.
The impetus for the development of these antibiotic-releasing
devices was based on two observations. The establishment of
infection peri-surgically, even with prophylaxis, [13,14] suggested
that either the organism was not sensitive to VAN or that the VAN-
sensitive organism had escaped due to acquisition of a ‘‘persister”
phenotype. To address the first concern, our device was designed
so that antibiotics with different spectra of activity could be used
singly or combined, allowing for additional coverage. In the second
case, because of the presence of persisters [60], even large doses of
VAN may be unable to sterilize a site. Fortunately, even with our
initial slow release, the pressure to remain in the persistent pheno-
type will be markedly reduced over the first several days and the
bacteria will tend to return to a more proliferative phenotype that
is again susceptible to antibiotics [60]. Thus, we reasoned that a
treatment followed by a pause, followed by a second treatment
would significantly decrease contaminating bacteria by reducing
numbers of persisters.
Persisters are known to be part of biofilms. We and others have
previously shown that SynF and blood cause aggregation of MSSA
and MRSA into floating biofilms and this affects metabolism and
antibiotic sensitivity [18–20]. In our experiments, MSSA preferen-
tially colonize the additive-manufactured PEEK surfaces even
though the control PS surfaces showed similar hydrophilicity after
conditioning with SynF or TSB. These small differences in numbers
were magnified in the presence of VAN, as surfaces in SynF
required 500 lg/ml of VAN vs. 100 lg/ml of VAN in TSB, suggesting
that persister formation may become even more important in
physiological fluid. Based on these reports and the data shown in
Fig. 5. Surface assessment of PEEK and PS. A) SEM imaging of PEEK (a) and PS (b) at 3.5kX magnification. Magnification: bar = 30 mm. B) Topographical map of roughness, as
measured by AFM, of PEEK (a) and PS (b). The roughness scale is shown to the right of each of the plots. C) Three dimensional representation of PEEK (a) and PS (b) topography.
Measured root mean square (RMS) roughness is shown for each sample (RMS ± SD).
Table 3
Contact angles.
PEEK PS
Dry 54 ± 5 69 ± 13
TSB 28 ± 8 64 ± 5
SynF 20 ± 3 0 ± 0
Contact angles in degrees, as a
function of pre-conditioning the
indicated surfaces with TSB or
SynF (n = 6), based on average of
the arctan of the ratio of height
to radius.
8 L.J. Delaney et al. / Acta Biomaterialia xxx (xxxx) xxx
Please cite this article as: L. J. Delaney, D. MacDonald, J. Leung et al., Ultrasound-triggered antibiotic release from PEEK clips to prevent spinal fusion infec-
tion: Initial evaluations, Acta Biomaterialia, https://doi.org/10.1016/j.actbio.2019.02.041
the present study, we strongly support the use of true, protein-
laden physiological fluid for measuring efficacy of antimicrobial
systems. Importantly, the >100 mg amounts needed to decrease
bacterial adhesion emphasize the limited utility of systems that
achieve ‘‘above MIC” amounts (MIC of VAN for sensitive S. aureus
is <2 lg/ml [61]) to decrease biofilm amounts in vivo. Importantly,
the >100–500 lg/ml levels eluted from our devices are sufficient
for eradication of MSSA biofilms, even those containing persisters.
Fortunately, it has been shown that US sensitizes adherent bac-
teria to antibiotics [21–23], so we do not anticipate that bacterial
colonization of the clip would occur during the time course of
the prophylaxis (0–7 d). Like any other implant, however, the sur-
face of the clip, which is small compared to the metal hardware,
could conceivably serve as an additional surface for bacterial colo-
nization. We do hypothesize that the interior reservoir, due to
small amounts of unescaped VAN and no flow, would still be rela-
tively inhospitable to bacteria – this will have to be determined in
animal experiments.
An additional concern is the fostering of resistant organisms.
Because of the high, temporally-limited, levels of antibiotics, it is
unlikely that prolonged selective pressure will exist on the resident
contaminants, allowing them to acquire resistance and overgrow
the suppressed population of bacteria. We specifically designed
this device for an US-mediated bolus release to minimize this pres-
sure. On the other hand, though when the antibiotic amounts are
large, concerns about biocompatibility arise. Based on our previous
data, we would expect the levels of VAN that are released from the
devices to fall within the acceptable range (<4 mg/24 h) [62].
Based on the above discussion, we had clear design parameters
that needed to be satisfied, i.e., a reservoir that could hold enough
antibiotic for bolus release, a membrane that could be ruptured
with US, and facilitated release of the antibiotic with insonation.
The porous PEEK pucks tested initially had sufficient porosity to
immobilize the large amounts of VAN required for effective eradi-
cation of MSSA. Once the PLA coating was ruptured by insonation,
particulate VAN (and perhaps PLA debris) was present both in the
puck and surrounding it. We suggest that the solubility of VAN was
exceeded in our elution volume and thus, much of the VAN
remained within the PEEK pucks. This situation would be different
under the fluid flow characteristic of biological systems [63]. When
the pucks were examined for VAN release, all pucks showed back-
ground release of VAN consistent with levels that would be consid-
ered antimicrobial. Based on our findings in these experiments,
more tuning of the coating process is necessary to improve consis-
tency of innate and US-triggered VAN release.
In many of the characterizations, we used the widely-accepted
MeB as a model drug. This was especially important with VAN,
whose spectrophotometric determination is hampered by a small
extinction coefficient (E1% = 40 (280 nm, in H2O, VAN) [64] vs.
E10mM = 30580 (600 nm in H2O, MeB) [65]). Depending on experi-
mental conditions, diffusion of MeB has been reported in the
range of 5.5  108 m2/s to 0.5  109 m2/s [66–68]. Therefore,
taken with our use of a shaker plate and 37 C submersion bath
to better simulate sink conditions experienced in vivo, our calcu-
lated value for MeB diffusion from our device agrees with pub-
lished values, and validates our model of release from our PEEK
clip devices.
Burst release tests demonstrated that 98% of the MeB loaded
into an uncoated PEEK reservoir was released at 10 h of submer-
sion. In contrast, even at 48 h, VAN elution was only 7.4 mg of
the possible 50 mg (15% of the total). Again, we suggest that
these differences are due to solubility and the fact that that the
VAN experiments were designed to test elution in 5–10 ml,
which is characteristic of post-surgical wound fluid (CKK, personal
communication). Work in living animals will be required to hone
antibiotic loading and release to allow complete bolus release. In
addition, studies are being conducted to determine the optimal
PLA coating thickness, as we found that the membrane thickness
and susceptibility to US-triggered rupture is highly tunable by
varying the concentration of PLA in the solution as well as the
number of coatings applied to the clip [69,70].
This study uses targeted US to mediate bulk drug release from
within a spinal hardware adjunct, and is one of only a handful of
studies investigating US-mediated bulk drug release. Previously,
Miyazaki et al. demonstrated US-facilitated release of insulin from
a polymeric implant placed subcutaneously in diabetic rats [71].
Animals receiving insonation at the implant site exhibited immedi-
ate decreases in blood glucose levels, signaling US-mediated
release of insulin [71]. Additionally, Kost et al. showed the tunable
effect of US pressure waves on degradation of polymers and the
release rate of molecules incorporated within these polymers
[72,73]. Otherwise, the majority of US-mediated drug delivery is
centered around the use of hydrogels, liposomes, and microbub-
bles for targeted delivery [74–79].
Study limitations include a limited sample size in vitro and
ex vivo, lack of fluid flow during the VAN elution experiments
resulting in saturated solutions of VAN, as well as the variability
in applying and determining coating thicknesses. Finally, complete
independence between sites in the ex vivomodel was assumed but
cannot be guaranteed.
The ultimate translational development of the device that we
have described will provide an important tool to spine surgeons
in their attempts to minimize the risk of infection. Currently, pro-
phylaxis is dependent on placement of VAN during surgical clo-
sure; additional prophylaxis is not used as it requires injection
and increased chances of infection. With the possibility of a wider
Fig. 6. Porous PEEK VAN reservoir for US release. A) Image of unloaded, 3D printed,
porous PEEK disc. B) Image of in vitro US-triggered VAN release from the PEEK
spacers. Blue box represents power Doppler imaging, focused on the spacer device.
Red areas are areas of increased streaming characteristic of a ruptured coating. C)
Summary of in vitro VAN release experiments. Values are from two independent
pucks sampled three times at each point. Histogram represents progressive VAN
release (not cumulative) at each time point; the line represents cumulative VAN
release from the time of immersion where all VAN amounts are expressed in lg. For
progressive release, the only two significant comparisons were before US vs. t = 0
(p = 0.005) and before US vs. t = 24 (p = 0.03); t = 0 vs. t = 24 was trending toward
significance (p = 0.08). For cumulative release, all comparisons were significant
(p < 0.01, exact values given in text).
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choice for antibiotics, i.e., Gram-positive and Gram-negative
targets, prophylaxis can be initiated by the VAN placement and
completed by the non-invasive release from the spinal clip. Thus,
by harnessing non-invasive US cavitation to effectively deliver high
levels of antibiotics, we anticipate that spinal infection rates will be
able to be markedly decreased.
Fig. 7. PLA coating and release from porous PEEK VAN reservoir A) SEM images of PEEK spacer surfaces, magnification 120. Magnification: bar = 200 mm. Aa) Uncoated PEEK
spacer showing porous material. Ab) PEEK spacer coated using 5–50 technique showing partially coated surface. Ac) PEEK spacer coated using 10–50 technique showing
partially coated surface, but more so than the 5–50 surface. Ad) PEEK spacer coated using 5–250 technique showing a completely coated, smooth surface. B) Innate MeB
release from the three coating techniques. C) Representative image of increased MeB release post-insonation.
Fig. 8. In vitro characterization of VAN release from 1-hole and 2-hole PEEK clip designs, represented as average ± SD, values are from three independent clips sampled twice
at each point. A) Elution of VAN from the 1-hole clip, *p = 0.0002, **p < 0.0001. B) Elution of VAN from the 2-hole clip.
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5. Conclusions
Existing methods for preventing peri-operative infection after
spinal fusion surgery are only partially successful. To combat this
clinical problem, we have designed an US-activated drug release
system that can release combinations of prophylactic antibiotics
to aggressively combat post-surgical bacterial survival, while
avoiding the problems of controlled elution systems. Ultimately,
a combination of antibiotics that target both Gram-positive and
Gram-negative bacteria would be loaded into the reservoir for a
broad approach to eradicating contaminating bacteria and pre-
venting infection.
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